Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) were up 7.2% during trading on Wednesday . The company traded as high as $29.18 and last traded at $29.23. Approximately 432,118 shares traded hands during trading, an increase of 4% from the average daily volume of 415,837 shares. The stock had previously closed at $27.27.
Wall Street Analyst Weigh In
A number of analysts have commented on PHR shares. Needham & Company LLC reaffirmed a "buy" rating and set a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. Canaccord Genuity Group increased their price target on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research report on Thursday, March 13th. JMP Securities restated a "market outperform" rating and issued a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Piper Sandler restated an "overweight" rating and issued a $33.00 price objective (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Finally, KeyCorp increased their price target on Phreesia from $28.00 to $30.00 and gave the company an "overweight" rating in a report on Wednesday, January 8th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $31.33.
View Our Latest Research Report on PHR
Phreesia Stock Performance
The firm's 50 day moving average price is $27.33 and its 200-day moving average price is $24.08. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of -18.68 and a beta of 1.03. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74.
Insider Transactions at Phreesia
In other news, SVP Amy Beth Vanduyn sold 1,311 shares of the firm's stock in a transaction on Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $34,885.71. Following the sale, the senior vice president now owns 115,633 shares in the company, valued at approximately $3,076,994.13. This trade represents a 1.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,982 shares of the firm's stock in a transaction on Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $105,961.02. Following the completion of the sale, the general counsel now owns 159,137 shares in the company, valued at approximately $4,234,635.57. The trade was a 2.44 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 162,442 shares of company stock worth $4,611,300. Insiders own 5.80% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in Phreesia by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company's stock worth $121,349,000 after purchasing an additional 61,048 shares during the period. Greenhouse Funds LLLP lifted its position in Phreesia by 27.9% in the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock worth $72,307,000 after purchasing an additional 626,579 shares during the period. Champlain Investment Partners LLC lifted its position in Phreesia by 4.1% in the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company's stock worth $57,062,000 after purchasing an additional 97,847 shares during the period. Franklin Resources Inc. lifted its position in Phreesia by 0.8% in the fourth quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock worth $37,982,000 after purchasing an additional 11,986 shares during the period. Finally, State Street Corp lifted its position in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company's stock worth $30,256,000 after purchasing an additional 88,517 shares during the period. 92.10% of the stock is owned by institutional investors.
About Phreesia
(
Get Free Report)
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Read More
Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
